Literature DB >> 32656722

Impact of comorbid conditions on disease-specific quality of life in older men and women with atrial fibrillation.

Hawa O Abu1, Jane S Saczynski2, John Ware3,4, Jordy Mehawej5, Tenes Paul5, Hamza Awad6, Benita A Bamgbade2, Isabelle C Pierre-Louis2, Mayra Tisminetzky4,7, Catarina I Kiefe4, Robert J Goldberg4, David D McManus5.   

Abstract

BACKGROUND: Older persons with atrial fibrillation (AF) experience significant impairment in quality of life (QoL), which may be partly attributable to their comorbid diseases. A greater understanding of the impact of comorbidities on QoL could optimize patient-centered care among older persons with AF.
OBJECTIVE: To assess impairment in disease-specific QoL due to comorbid conditions in older adults with AF.
METHODS: Patients aged ≥ 65 years diagnosed with AF were recruited from five medical centers in Massachusetts and Georgia between 2015 and 2018. At 1 year of follow-up, the Quality of Life Disease Impact Scale-for Multiple Chronic Conditions was used to provide standardized assessment of patient self-reported impairment in QoL attributable to 34 comorbid conditions grouped in 10 clusters.
RESULTS: The mean age of study participants (n = 1097) was 75 years and 48% were women. Overall, cardiometabolic, musculoskeletal, and pulmonary conditions were the most prevalent comorbidity clusters. A high proportion of participants (82%) reported that musculoskeletal conditions exerted the greatest impact on their QoL. Men were more likely than women to report that osteoarthritis and stroke severely impacted their QoL. Patients aged < 75 years were more likely to report that obesity, hip/knee joint problems, and fibromyalgia extremely impacted their QoL than older participants.
CONCLUSIONS: Among older persons with AF, while cardiometabolic diseases were highly prevalent, musculoskeletal conditions exerted the greatest impact on patients' disease-specific QoL. Understanding the extent of impairment in QoL due to underlying comorbidities provides an opportunity to develop interventions targeted at diseases that may cause significant impairment in QoL.

Entities:  

Keywords:  Atrial fibrillation; Comorbidities; Disease-specific quality of life; Older adults

Mesh:

Year:  2020        PMID: 32656722      PMCID: PMC7686243          DOI: 10.1007/s11136-020-02578-3

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   3.440


  42 in total

1.  Quality of life during and after inpatient stroke rehabilitation.

Authors:  Wilma M Hopman; Jane Verner
Journal:  Stroke       Date:  2003-02-13       Impact factor: 7.914

2.  A meta-analysis of sex differences prevalence, incidence and severity of osteoarthritis.

Authors:  Velandai K Srikanth; Jayne L Fryer; Guangju Zhai; Tania M Winzenberg; David Hosmer; Graeme Jones
Journal:  Osteoarthritis Cartilage       Date:  2005-09       Impact factor: 6.576

3.  The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Authors:  Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow
Journal:  J Am Geriatr Soc       Date:  2005-04       Impact factor: 5.562

Review 4.  Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis.

Authors:  M Blagojevic; C Jinks; A Jeffery; K P Jordan
Journal:  Osteoarthritis Cartilage       Date:  2009-09-02       Impact factor: 6.576

5.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

6.  Health-related quality of life, psychological distress, and symptom burden in an Asian population of outpatients with atrial fibrillation.

Authors:  Hui Ching Tan; Karen Wei Ling Koh; Vivien Xi Wu; Toon Wei Lim; Wenru Wang
Journal:  Heart Lung       Date:  2018-05-22       Impact factor: 2.210

7.  Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation.

Authors:  Anthony P Kent; Martina Brueckmann; Mandy Fraessdorf; Stuart J Connolly; Salim Yusuf; John W Eikelboom; Jonas Oldgren; Paul A Reilly; Lars Wallentin; Michael D Ezekowitz
Journal:  J Am Coll Cardiol       Date:  2018-07-09       Impact factor: 24.094

8.  Multimorbidity and the risk of hospitalization and death in atrial fibrillation: A population-based study.

Authors:  Alanna M Chamberlain; Alvaro Alonso; Bernard J Gersh; Sheila M Manemann; Jill M Killian; Susan A Weston; Margaret Byrne; Véronique L Roger
Journal:  Am Heart J       Date:  2016-12-09       Impact factor: 4.749

9.  Hospitalizations in patients with atrial fibrillation: an analysis from ROCKET AF.

Authors:  Adam D DeVore; Anne S Hellkamp; Richard C Becker; Scott D Berkowitz; Guenter Breithardt; Werner Hacke; Jonathan L Halperin; Graeme J Hankey; Kenneth W Mahaffey; Christopher C Nessel; Daniel E Singer; Keith A A Fox; Manesh R Patel; Jonathan P Piccini
Journal:  Europace       Date:  2016-05-12       Impact factor: 5.214

10.  The Impact of Risk Factors and Comorbidities on The Incidence of Atrial Fibrillation.

Authors:  Nabil Naser; Mirza Dilic; Azra Durak; Mehmed Kulic; Esad Pepic; Elnur Smajic; Zumreta Kusljugic
Journal:  Mater Sociomed       Date:  2017-12
View more
  1 in total

1.  Multimorbidity, physical frailty, and self-rated health in older patients with atrial fibrillation.

Authors:  Hawa O Abu; Jane Saczynski; Jordy Mehawej; Tenes Paul; Hamza Awad; Benita A Bamgbade; Isabelle C Pierre-Louis; Mayra Tisminetzky; Catarina I Kiefe; Robert J Goldberg; David D McManus
Journal:  BMC Geriatr       Date:  2020-09-11       Impact factor: 4.070

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.